Prokidney (PROK) Other Accumulated Expenses (2021 - 2026)
Prokidney's (PROK) quarterly Other Accumulated Expenses came in at $1.4 million in Q1 2026, down 14.84% year-on-year from $1.6 million in Q1 2025, and up 106.45% on a QoQ basis from $667000.0 in Q4 2025.
Prokidney (PROK) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Other Accumulated Expenses data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses fell 14.84% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 14.84% decrease from a year earlier, with the FY2025 full-year figure at $667000.0, down 65.1% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $1.4 million, up from $667000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for PROK reached as high as $2.6 million in Q3 2024 and fell as low as $21000.0 in Q4 2022.
- Historically, Other Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $1.4 million in 2026.
- Across the five-year window, Other Accumulated Expenses sank 85.91% in 2022 and soared 7214.29% in 2023, its largest moves.
- Year by year, Other Accumulated Expenses stood at $21000.0 in 2022, then surged by 7214.29% to $1.5 million in 2023, then increased by 24.41% to $1.9 million in 2024, then sank by 65.1% to $667000.0 in 2025, then surged by 106.45% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.4 million in Q1 2026, $667000.0 in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 667,000.00 |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 542,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 537,000.00 |
| Dec 31, 2021 | 149,000.00 |